| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.0M | -8.7% |
| Cost of Revenue | $12.7M | -13.3% |
| Gross Profit | $1.3M | +89.1% |
| R&D Expense | $771K | -36.9% |
| SG&A Expense | $3.9M | -8.9% |
| Operating Income | -$4.4M | +27.0% |
| Net Income | -$4.7M | +28.6% |
| EPS (Basic) | -$1.86 | -279.6% |
| EPS (Diluted) | -$1.86 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $498K | -9.3% |
| Accounts Receivable | $2.2M | +28.5% |
| Inventory | $12.9M | -22.0% |
| Current Assets | $15.6M | -29.1% |
| Total Assets | $17.5M | -30.5% |
| Current Liabilities | $8.6M | -16.2% |
| Total Liabilities | $9.0M | -25.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$536K | +84.4% |
| Capital Expenditures | $19K | -90.2% |
| Investing Cash Flow | -$19K | +90.2% |
| Financing Cash Flow | $504K | -87.3% |
| Free Cash Flow | -$555K | +84.7% |
| -279.6% |
| Stockholders' Equity |
| $8.5M |
| -35.5% |